Zacks Research Issues Negative Forecast for Neogen Earnings

Neogen Co. (NASDAQ:NEOG) – Research analysts at Zacks Research decreased their Q1 2026 earnings per share (EPS) estimates for Neogen in a research report issued on Wednesday, April 30th. Zacks Research analyst R. Department now forecasts that the company will post earnings per share of $0.09 for the quarter, down from their previous forecast of $0.11. The consensus estimate for Neogen’s current full-year earnings is $0.38 per share. Zacks Research also issued estimates for Neogen’s Q3 2026 earnings at $0.11 EPS, Q4 2026 earnings at $0.10 EPS, FY2026 earnings at $0.42 EPS, Q1 2027 earnings at $0.11 EPS and Q2 2027 earnings at $0.13 EPS.

Neogen (NASDAQ:NEOG) last issued its quarterly earnings data on Wednesday, April 9th. The company reported $0.10 earnings per share for the quarter, missing analysts’ consensus estimates of $0.12 by ($0.02). The business had revenue of $221.00 million during the quarter, compared to the consensus estimate of $225.27 million. Neogen had a positive return on equity of 2.89% and a negative net margin of 52.12%. Neogen’s quarterly revenue was down 3.4% compared to the same quarter last year. During the same quarter in the prior year, the business posted $0.12 earnings per share.

Several other equities analysts have also recently issued reports on NEOG. Piper Sandler reduced their price target on shares of Neogen from $6.40 to $5.00 and set a “neutral” rating on the stock in a research report on Tuesday, April 22nd. Guggenheim reduced their target price on Neogen from $15.00 to $13.00 and set a “buy” rating on the stock in a report on Thursday, April 10th.

Neogen Stock Performance

NASDAQ:NEOG opened at $5.75 on Friday. The company has a quick ratio of 2.46, a current ratio of 3.77 and a debt-to-equity ratio of 0.33. Neogen has a twelve month low of $3.87 and a twelve month high of $18.58. The stock has a market cap of $1.25 billion, a P/E ratio of -2.63 and a beta of 1.57. The firm’s fifty day simple moving average is $7.50 and its 200 day simple moving average is $10.91.

Insider Activity

In related news, CAO John Patrick Moylan purchased 10,000 shares of the company’s stock in a transaction dated Thursday, April 10th. The shares were purchased at an average cost of $5.07 per share, with a total value of $50,700.00. Following the transaction, the chief accounting officer now directly owns 10,000 shares in the company, valued at $50,700. This trade represents a ∞ increase in their position. The purchase was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through this link. Also, Director James C. Borel acquired 35,000 shares of Neogen stock in a transaction that occurred on Thursday, April 24th. The shares were bought at an average cost of $4.89 per share, with a total value of $171,150.00. Following the transaction, the director now owns 60,474 shares in the company, valued at $295,717.86. This represents a 137.39 % increase in their ownership of the stock. The disclosure for this purchase can be found here. In the last 90 days, insiders have acquired 67,500 shares of company stock worth $331,525. Corporate insiders own 1.13% of the company’s stock.

Institutional Trading of Neogen

Institutional investors have recently bought and sold shares of the company. Barclays PLC lifted its stake in shares of Neogen by 129.8% in the third quarter. Barclays PLC now owns 366,753 shares of the company’s stock worth $6,165,000 after buying an additional 207,160 shares in the last quarter. Franklin Resources Inc. raised its holdings in Neogen by 33.9% in the 3rd quarter. Franklin Resources Inc. now owns 923,918 shares of the company’s stock worth $15,531,000 after acquiring an additional 233,796 shares during the last quarter. Diversified Trust Co lifted its position in Neogen by 7.1% in the 4th quarter. Diversified Trust Co now owns 74,446 shares of the company’s stock valued at $904,000 after acquiring an additional 4,961 shares in the last quarter. Harbor Capital Advisors Inc. boosted its stake in Neogen by 32.1% during the 4th quarter. Harbor Capital Advisors Inc. now owns 1,303,465 shares of the company’s stock valued at $15,824,000 after purchasing an additional 316,457 shares during the last quarter. Finally, Procyon Advisors LLC increased its holdings in shares of Neogen by 22.3% in the 4th quarter. Procyon Advisors LLC now owns 35,513 shares of the company’s stock worth $431,000 after purchasing an additional 6,467 shares in the last quarter. 96.73% of the stock is owned by hedge funds and other institutional investors.

About Neogen

Neogen Corporation, together with its subsidiaries, engages in the development, manufacture, and marketing of various products and services dedicated to food and animal safety worldwide. It operates through two segments, Food Safety and Animal Safety. The Food Safety segment offers diagnostic test kits and related products to detect dangerous and unintended substances in food and animal feed, including foodborne pathogens, spoilage organisms, natural toxins, food allergens, genetic modifications, ruminant by-products, meat speciation, drug residues, pesticide residues, and general sanitation concerns; and AccuPoint Advanced rapid sanitation test to detect the presence of adenosine triphosphate, a chemical found in living cells, as well as provides genomics-based diagnostic technology and software systems that help testers to objectively analyze and store their results and perform analysis on the results from multiple locations over extended periods.